Meet the Team


Robert Barr

Chairman of the Board

Robert is the Non-Executive Chairman of Quantum Imaging. He is Group Chief Executive and co-owner of Arran Isle Ltd and is Non-Executive Chairman of AHR-Global, a creative architectural and design consultancy.

Prior to his role at Aran Isle, Robert was the Chief Operating Officer of Kingspan Group plc. and previously, was Managing Director (Europe) and a main Board Director of Bespak plc. Robert spent his early career in various international management roles at Diageo plc.


Steve Parker

Chief Executive Officer

Steve has held a series of senior roles in International Medical Device companies over a period of 35 years. Starting his career with roles in engineering, marketing and sales with Marquette Electronics (later to become part of GE Medical Systems) and various national management roles at St Jude Medical inc.

Steve also served as European Director of Sales and Marketing for Vasomedical inc. and Managing Director of i-STAT Ltd. responsible for all European operations. Most recently he was Senior Director, International Commercial Operations, at Abbott Laboratories with divisional commercial responsibility for all markets outside of North America.


Prof Ben Varcoe

Chief Scientific Officer

Ben is a Professor in the Department of Physics and Astronomy at the University of Leeds and Chair of Experimental Quantum Information Science. He is a fellow of the Engineering and Physical Sciences Research Council and member of its College of experts. From 1997-2001 he worked at the Max Planck Institute for Quantum Optics in Germany where he led a team that saw the world’s first unambiguous demonstration of photon quantisation.

Ben is one of the leading experimentalists of precision measurements in the UK and has applied the principles of quantum metrology to a number of applications, including magnetocardiography.


Dr Simon Graindorge

Non-Executive Director

Simon has a strong background of investing in, and building, high growth technology spinouts across the healthcare sector with a focus on medical devices and diagnostics, software, regenerative medicine, digital health and medical technologies. Simon is on the board of a number of IP Group’s healthcare portfolio companies.

Simon joined IP Group from Ceramex Ltd, a corporate spin-out of the Hexadex Group, where he was Operations Director. Prior to this, he was Commercial Director at Tissue Regenix Group, the regenerative medical devices company, a company he helped found during his time at IP2IPO (now IP Group).


Dr Sarah Jarmin

Non-Executive Director

Sarah manages the commercialisation of intellectual property emerging from the Health, Medicine and Life Sciences faculties at the University of Leeds.

She has held postdoctoral positions at Imperial College London and the University of Leeds and prior to joining the University of Leeds Sarah worked on IP portfolio management, licensing and spin-out opportunities as well as academic engagement and supported the establishment of impact and innovation vehicles in a range of technology sectors at the University of Bradford.


Dave Dimambro

Technical Director

Dave has led engineering and technology developments in medical device, pharma, and broadcast sectors. He began his career over 30 years ago with the BBC building new broadcast systems overseas. He was previously Engineering Director for Oxford based Penlon, where he successfully delivered a range of new Anaesthesia products.

Dave has also held a number of Operations Director positions where he has led project management service management, manufacturing and change management functions.


Dr Greg Shipp

Director Quality, Regulatory and Clinical Strategy

Greg has held roles in Medical Device companies and consulting firms over a period of 27 years. He started his career with positions in research engineering with PhysioControl (subsidiary of Eli Lilly) and subsequent clinical and regulatory affairs positions with Quinton Instruments and Boston Scientific.

Greg has most recently held a VP Medical Affairs role at Abbott Laboratories (previously i-STAT) and VP Clinical, Regulatory and Medical Affairs at Nanosphere. He has been on multiple national advisory committees including the International Laboratory Medicine Guidelines and National Cancer Institute (NCI) SBIR Grants committees.

Greg has degrees in biomedical engineering from Northwestern University and a medical degree from the University of North Carolina School of Medicine, with a medical residency in Diagnostic Radiology at the University of Chicago.